{
 "company": "inovalon",
 "as_of": "2026-10-01",
 "choices": [
  {
   "id": "inovalon-p01",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Initial job",
   "statement": "The company started in 1998 analyzing data that supported health plans' compliance with quality and accreditation standards.",
   "event_date": "1998",
   "date_precision": "year",
   "evidence_kind": "participant_account",
   "sources": [
    "INV2"
   ]
  },
  {
   "id": "inovalon-p02",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Data collection systems",
   "statement": "Early systems gathered and validated healthcare data from providers and facilities; by the early 2000s the focus shifted to aggregating large datasets to measure quality outcomes.",
   "event_date": "1998",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV16"
   ]
  },
  {
   "id": "inovalon-p03",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Certified HEDIS engine",
   "statement": "By 2012 QSI had passed NCQA certification 11 years in a row, a record dating from 2001, when certification began.",
   "event_date": "2001",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV33"
   ]
  },
  {
   "id": "inovalon-p04",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Quality outcomes measurement",
   "statement": "The company launched its clinical quality outcomes measurement solution, later the base of Converged Quality.",
   "event_date": "2003",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-p23",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Own quality measurement product",
   "statement": "The company launched a clinical quality outcomes measurement solution aggregating data for plans reporting to NCQA, CMS and state health departments.",
   "event_date": "2003",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-g01",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Land with HEDIS",
   "statement": "Clarian Health Plans started buying NCQA HEDIS analytics in 2008.",
   "event_date": "2008",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV21"
   ]
  },
  {
   "id": "inovalon-p05",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Clinical intervention products",
   "statement": "The 2008 line included CCS Advantage disease management, ePASS patient assessment, ISAP patient stratification, the iDCT data collection tool and SRSA site review.",
   "event_date": "2008-09",
   "date_precision": "month",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV17"
   ]
  },
  {
   "id": "inovalon-g06",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Self-funded with one outside investor",
   "statement": "Andre Hoffmann bought $175 million of stock, taking just over 15% and a board seat as the largest outside shareholder.",
   "event_date": "2008-09-17",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV17"
   ]
  },
  {
   "id": "inovalon-g05",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Plan coverage",
   "statement": "After Catalyst the company served over 200 managed care organizations, including half of the top 20.",
   "event_date": "2009-09",
   "date_precision": "month",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV18"
   ]
  },
  {
   "id": "inovalon-p06",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Catalyst acquisition",
   "statement": "MedAssurant bought Catalyst Technologies, described as the leading provider of HEDIS administrative software used to report to NCQA and CMS.",
   "event_date": "2009-09-11",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV18"
   ]
  },
  {
   "id": "inovalon-p24",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Acquired HEDIS engine",
   "statement": "Catalyst brought HEDIS administrative software and a proprietary analytical rules compiler; Catalyst had been NCQA-certified since 2001 [INV42].",
   "event_date": "2009-09-11",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV18"
   ]
  },
  {
   "id": "inovalon-p07",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "MORE2 Registry",
   "statement": "The company formalized its de-identified dataset as the MORE2 Registry.",
   "event_date": "2010",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-g02",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Expand into risk and quality",
   "statement": "Clarian expanded in 2010 to the integrated suite for risk data accuracy, clinical quality, utilization and outcomes.",
   "event_date": "2010-10-06",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV21"
   ]
  },
  {
   "id": "inovalon-p09",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Star Advantage",
   "statement": "Star Advantage was launched for Medicare Star ratings.",
   "event_date": "2011",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-g03",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Expansion at Healthfirst",
   "statement": "Healthfirst expanded its use to clinical data accuracy, claims analytics and Prospective Advantage across Medicare and Medicaid members.",
   "event_date": "2011-03-23",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV20"
   ]
  },
  {
   "id": "inovalon-p08",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Medicare Advantage suite",
   "statement": "The Medicare Advantage suite combined Star quality management, HEDIS, Prospective Advantage, capitated risk adjustment (CARA), claims aggregation and submission (CAAS), care coordination and business intelligence.",
   "event_date": "2011-04-18",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV19"
   ]
  },
  {
   "id": "inovalon-g04",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Integrated suite sale",
   "statement": "Blue Cross Blue Shield of Michigan implemented eight solutions for Medicare Advantage; Dunleavy pitched one coordinated data feed replacing disparate systems.",
   "event_date": "2011-04-18",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV19"
   ]
  },
  {
   "id": "inovalon-p10",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "HEDIS reach",
   "statement": "QSI was described as the most widely used HEDIS solution, supporting quality calculations for about 60% of the insured population.",
   "event_date": "2012-01-13",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV33"
   ]
  },
  {
   "id": "inovalon-g24",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Research showcase",
   "statement": "Registry studies were presented at the 2014 ISPOR outcomes-research meeting.",
   "event_date": "2014-06-02",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV27"
   ]
  },
  {
   "id": "inovalon-p11",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Registry size",
   "statement": "The MORE2 Registry held more than 9.1 billion medical events on 118 million patients and had grown about 43.3% a year since 2000.",
   "event_date": "2014-09-30",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV7"
   ]
  },
  {
   "id": "inovalon-g08",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Client concentration",
   "statement": "The top four clients were 12%, 11%, 11% and 10% of 2013 revenue, and the top ten about 70% to 75%.",
   "event_date": "2014-12-30",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV7"
   ]
  },
  {
   "id": "inovalon-g11",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Top plans",
   "statement": "In 2015 clients included 20 of the top 25 health plans; Anthem was about 12% of revenue and the top ten 68%.",
   "event_date": "2015",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV23"
   ]
  },
  {
   "id": "inovalon-g12",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Contract length",
   "statement": "Client contracts generally ran two to four years.",
   "event_date": "2015",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV23"
   ]
  },
  {
   "id": "inovalon-p22",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "EHR and retail integrations",
   "statement": "By 2014 the platform integrated with EHR vendors such as Allscripts and Greenway and with Walgreens clinics.",
   "event_date": "2015-01-05",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV24"
   ]
  },
  {
   "id": "inovalon-p12",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Data reuse",
   "statement": "Data received in the course of providing services were statistically de-identified and stored in the MORE2 Registry.",
   "event_date": "2015-01-29",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV3"
   ]
  },
  {
   "id": "inovalon-p13",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Software versus services mix",
   "statement": "In 2013 data analytics subscriptions were 48.6% of revenue and data-driven intervention services 51.4%, mostly partially automated work.",
   "event_date": "2015-01-29",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV3"
   ]
  },
  {
   "id": "inovalon-g07",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Independence positioning",
   "statement": "The prospectus stressed that the company was not owned or influenced by a health plan or private equity firm, so its data and analyses were independent.",
   "event_date": "2015-01-29",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV3"
   ]
  },
  {
   "id": "inovalon-g10",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Founder control",
   "statement": "Ten-vote Class B shares held by pre-IPO holders kept about 98% of voting power after the offering.",
   "event_date": "2015-01-29",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV3"
   ]
  },
  {
   "id": "inovalon-g13",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Adjacent buyers",
   "statement": "The IPO growth plan named providers, pharma, employers and consumers as adjacent markets, plus channel partnerships and acquisitions.",
   "event_date": "2015-01-29",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV3"
   ]
  },
  {
   "id": "inovalon-g09",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "IPO",
   "statement": "The company listed on Nasdaq at $27 a share, selling 22.2 million shares for about $600 million.",
   "event_date": "2015-02",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV8"
   ]
  },
  {
   "id": "inovalon-g14",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Avalere",
   "statement": "Inovalon bought Avalere Health, a Washington policy and life sciences advisory firm.",
   "event_date": "2015-09-01",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV38"
   ]
  },
  {
   "id": "inovalon-p14",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Chart retrieval and in-home work",
   "statement": "Intervention capabilities ran by telephone, in patients' homes and in clinics; SRSA handled facility scheduling, on-site abstraction, review and quality control of medical records.",
   "event_date": "2016",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV4"
   ]
  },
  {
   "id": "inovalon-p15",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Own software",
   "statement": "The company built its own software and described its platform components as modular, supported by the depth of the registry.",
   "event_date": "2016",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV4"
   ]
  },
  {
   "id": "inovalon-p16",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "EHR connectivity",
   "statement": "EHR connectivity reached more than 100,000 providers during 2016.",
   "event_date": "2016",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV29"
   ]
  },
  {
   "id": "inovalon-g15",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Life sciences and provider clients",
   "statement": "In 2016 clients included 219 of 1,377 life sciences organizations and 133 provider organizations; Anthem was 17% of revenue.",
   "event_date": "2016",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV4"
   ]
  },
  {
   "id": "inovalon-g27",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Older product line migration",
   "statement": "Clients shifted purchasing away from an older product line faster than planned; the company converted them to a modular platform at a short-term revenue cost.",
   "event_date": "2016-08-04",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV50"
   ]
  },
  {
   "id": "inovalon-p17",
   "business": "Provider connectivity and life sciences data",
   "category": "product",
   "dimension": "Specialty pharmacy software",
   "statement": "The company entered specialty pharmacy software by buying Creehan & Company (later ScriptMed).",
   "event_date": "2016-10",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-g16",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Failed collaboration",
   "statement": "An expected multi-year collaboration worth about $40 million of fourth-quarter revenue collapsed, and 2016 revenue guidance fell from $470-490 million to $426-428 million.",
   "event_date": "2016-12-13",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV6"
   ]
  },
  {
   "id": "inovalon-g23",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Client count",
   "statement": "Clients rose to 451 in 2016 from 372, with 58 multi-year statements of work.",
   "event_date": "2017-02-22",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV29"
   ]
  },
  {
   "id": "inovalon-g28",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Revenue mix shift",
   "statement": "Payers fell from 83% of revenue in 2015 to 69% in 2017; pharma and life sciences were 14% to 15% and providers rose to 15%.",
   "event_date": "2018-02",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV45"
   ]
  },
  {
   "id": "inovalon-g18",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Less reliance on plans",
   "statement": "The ABILITY deal was reported as giving Inovalon scale and lessening its reliance on insurance companies.",
   "event_date": "2018-03",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV14"
   ]
  },
  {
   "id": "inovalon-p18",
   "business": "Provider connectivity and life sciences data",
   "category": "product",
   "dimension": "ABILITY platform",
   "statement": "The ABILITY acquisition added myABILITY, a cloud connectivity, administrative and quality platform used by more than 44,000 provider facilities.",
   "event_date": "2018-03-07",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV13"
   ]
  },
  {
   "id": "inovalon-g17",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Debt-financed provider reach",
   "statement": "ABILITY was bought for $1.2 billion, funded with a $980 million term loan, cash and $100 million of restricted stock.",
   "event_date": "2018-03-07",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV13"
   ]
  },
  {
   "id": "inovalon-g19",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Subscription shift",
   "statement": "Subscription platform revenue was $585.1 million of $667.5 million in 2020 and 86% of fourth-quarter revenue.",
   "event_date": "2020",
   "date_precision": "year",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV39"
   ]
  },
  {
   "id": "inovalon-p19",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "Inovalon ONE",
   "statement": "The offering was presented as the Inovalon ONE Platform, informed by data on 338 million Americans and 63 billion medical events.",
   "event_date": "2021-08-19",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV30"
   ]
  },
  {
   "id": "inovalon-g20",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Top accounts",
   "statement": "Customers included all of the top 25 US health plans, the top 25 global drug companies and 24 of the top 25 provider systems.",
   "event_date": "2021-08-19",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV30"
   ]
  },
  {
   "id": "inovalon-g21",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Take-private",
   "statement": "A Nordic Capital-led consortium with Insight Partners completed the purchase at $41 a share; Dunleavy rolled equity and stayed CEO.",
   "event_date": "2021-11-24",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV9"
   ]
  },
  {
   "id": "inovalon-g22",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Avalere sold",
   "statement": "Avalere was sold to Fishawack Health in 2022.",
   "event_date": "2022-06",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV38"
   ]
  },
  {
   "id": "inovalon-g26",
   "business": "Health plan quality and risk analytics",
   "category": "go_to_market",
   "dimension": "Buyer survey",
   "statement": "A 2024 Black Book survey of payer users ranked the payer platform first for a fourth year, ahead of Optum and others.",
   "event_date": "2024",
   "date_precision": "year",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV31"
   ]
  },
  {
   "id": "inovalon-p20",
   "business": "Provider connectivity and life sciences data",
   "category": "product",
   "dimension": "VigiLanz",
   "statement": "The company acquired VigiLanz, a clinical surveillance and patient safety software and data company.",
   "event_date": "2024-02",
   "date_precision": "month",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV15"
   ]
  },
  {
   "id": "inovalon-p25",
   "business": "Health plan quality and risk analytics",
   "category": "product",
   "dimension": "HEDIS default",
   "statement": "Converged Quality earned its 26th consecutive NCQA HEDIS certification and processed measures for over 85% of HEDIS covered lives, including 12 of the top 15 plans.",
   "event_date": "2026-07-23",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV56"
   ]
  },
  {
   "id": "inovalon-p21",
   "business": "Provider connectivity and life sciences data",
   "category": "product",
   "dimension": "Linked real-world data",
   "statement": "Inovalon linked its closed-claims data (248 million lives) with OMNY Health EHR data and clinical notes for researchers.",
   "event_date": "2026-08-11",
   "date_precision": "day",
   "evidence_kind": "documented_offer_or_action",
   "sources": [
    "INV32"
   ]
  },
  {
   "id": "inovalon-g25",
   "business": "Provider connectivity and life sciences data",
   "category": "go_to_market",
   "dimension": "Life sciences data products",
   "statement": "Life sciences buyers are offered de-identified real-world data from over 160 sources covering over half of the insured population.",
   "event_date": "2026-10-01",
   "date_precision": "day",
   "evidence_kind": "company_described_offering",
   "sources": [
    "INV28"
   ]
  }
 ]
}